ICD-10-CM Billable Code

H21.261

Iris atrophy (essential) (progressive), right eye

Clinical Classification Guidelines

Medical Intelligence & Overview

Iris atrophy, also known as progressive iris atrophy, is a condition characterized by the gradual deterioration or thinning of the iris tissue in the eye. When it affects only the right eye, healthcare providers categorize it under the specific ICD-10 code H21.261. This condition impacts the eye's appearance and may influence its function, potentially leading to vision changes. While not always linked to significant vision loss, understanding iris atrophy can help in recognizing symptoms and seeking appropriate eye care.

Causes & Symptoms

Clinical Causes: Age-related degeneration: Natural aging processes can lead to thinning of iris tissue. Inflammatory eye conditions: Conditions such as uveitis may cause tissue damage. Trauma to the eye: Physical injury can result in iris damage and atrophy. Genetic factors: Some individuals may inherit predispositions to iris tissue degeneration. Medical conditions: Disorders like pigment dispersion syndrome or certain eye tumors may contribute. Previous eye surgeries: Surgical procedures can occasionally damage the iris tissue. Unknown factors: In some cases, the exact cause remains unidentified.

Key Symptoms: Change in eye color: The iris may appear lighter or more faded. Protrusion or thinning: Noticeable thinning of the iris tissue may be observed. Irregular pupil shape: Pupils may become misshapen or irregularly sized. Light sensitivity: Increased sensitivity to bright light or glare. Visual disturbances: Problems with focusing or temporary vision issues under certain lighting conditions. Cosmetic concerns: Changes in eye appearance that may be aesthetically noticeable.

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a comprehensive eye examination by a qualified ophthalmologist. The specialist will examine the iris's appearance, shape, and tissue integrity, often using slit-lamp biomicroscopy to observe detailed features. Additional tests, such as intraocular pressure measurement or imaging techniques, may be employed to exclude other eye conditions. A detailed patient history to identify possible causes or associated conditions is also part of the diagnostic process.

Treatment Protocols: There is no specific treatment to reverse iris atrophy itself. Management focuses on monitoring the condition and addressing symptoms or complications if they arise. In cases where associated issues like glaucoma develop, appropriate interventions such as medications or surgical procedures may be necessary. Protective measures, including wearing sunglasses to reduce light sensitivity, can enhance comfort. Regular eye check-ups are important to monitor disease progression and maintain eye health.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is H21.261 a billable ICD-10 code?
Yes, H21.261 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report H21.261?
Clinical documentation must specify the nature of Iris atrophy (essential) (progressive), right eye and any associated comorbidities for accurate reporting.

Cite this Clinical Reference